MASSMASSHealthcare · Medical Devices

MASS Stock Forecast: 908 Devices, Inc. Price Predictions for 2026-2027

Last close, 20 Nov 2026
$8.67
−7.47% on the day

The median 12-month analyst price target for 908 Devices, Inc. is $14. Ticker Nerd's systematic factor model, run across ~4,300 US stocks, ranks it 77 of 100 as at 21 Nov 2026 — inside the top quartile.

Market cap
$360.5M
Ticker Nerd rank
77/ 100
Median analyst target
$14
Analysts covering
6
Revenue$16.1M+23.3% y/y
Operating income−$6.4M
Net income−$11.9M
Free cash flow$3.0M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−11.0%
1M
−24.7%
YTD
+65.1%
1Y
+52.1%
From 52W high
−32.6%
From 52W low
+70.3%
$5
$13
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

One number for the whole business

Consensus tells you what everyone already believes. The model scores 908 Devices, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 21 Nov 2026
77/ 100

Percentile across ~4,300 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Growth
87
Quality
78
Momentum
78
Accruals
71
Value
64
Volatility
47
Revisions
47
Issuance
29

Growth (87): Sales and profits are climbing, and climbing faster than before.

Issuance (29): The company has been issuing shares or taking on financing, diluting existing holders.

Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.

Wall Street

MASS stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on MASS, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$4$6$8$10$12$14Jan 26Apr 26Jul 26Oct 26MASSHigh $14Median $14Low $14

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says6 analysts
6
Buy
0
Hold
0
Sell
$14
Low
$14
Median
$14
High
Recent analyst actionsNewest first

Of the 20 most recent actions, 4 moved their price target up and 0 moved it down.

DateFirmActionRatingTarget
12 Nov 2026Canaccord GenuityMaintainsBuy$14 → $14
11 Nov 2026StifelMaintainsBuy$12 → $14
10 Sept 2026Canaccord GenuityInitiatesBuy$14
12 Aug 2026Roth CapitalMaintainsBuy$11 → $13
12 Aug 2026StifelMaintainsBuy$10 → $12
29 July 2026Roth CapitalInitiatesBuy$11
5 Aug 2025Leerink PartnersUpgradeOutperform$12
15 Jan 2025Stephens & Co.ReiteratesOverweight—
13 Nov 2024Leerink PartnersDowngradeMarket Perform—
13 Nov 2024StifelMaintainsBuy—
17 Oct 2024Leerink PartnersMaintainsOutperform—
13 May 2024Stephens & Co.ReiteratesOverweight—
25 Sept 2023Stephens & Co.ReiteratesOverweight—
7 Feb 2023Stephens & Co.InitiatesOverweight—
6 Jan 2023SVB LeerinkMaintainsOutperform—
15 Nov 2022SVB LeerinkMaintainsOutperform—
8 Mar 2022SVB LeerinkMaintainsOutperform—
14 May 2021SVB LeerinkMaintainsOutperform—
12 Jan 2021Cowen & Co.InitiatesOutperform—
12 Jan 2021StifelInitiatesBuy—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Wall Street targets run 12 to 18 months out. No analyst publishes a 2030 price target for MASS.

Market Radar

This page is one stock. Monday covers all of them.

MASS appears in the Radar on the weeks it earns a place.

  • Market Radar, every Monday: the week's biggest rank moves across ~4,300 US stocks, and the reason for each.
  • The AI build-out map, free: every AI company we track on one page, with the model's Top picks in all four parts.

Free. Unsubscribe any time. Privacy

The AI build-out map
PDF
  • AI cloud capacity

    MSFTAMZNGOOGLORCL

  • AI chips

    NVDAAVGOAMDMU

  • AI networking and servers

    ANETDELLLITECRDO

  • Data centre power

    VRTCEGGEVVST

Performance

MASS vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 20 Nov 2026, 908 Devices, Inc. returned +52.1% against +6.9% for the S&P 500, dividends included.

MASS vs S&P 500, last 12 monthsTotal return, rebased to 100
100150200Jan 26Apr 26Jul 26Oct 26MASSS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

MASS analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingThis fiscal year
Analysts raising
1
Analysts cutting
0
Fundamentals

Financials

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
—
Price / sales
5.5×

Cheaper than 20% of US stocks

Price / book
2.4×

Cheaper than 38% of US stocks

EV / EBITDA
—
Growth & margins
Revenue growth (YoY)
—
Earnings growth (YoY)
—
Gross margin
51.9%

Higher than 64% of US stocks

Operating margin
−30.6%

Higher than 21% of US stocks

Net margin
—
Returns & dividend
Return on equity
−16.8%

Higher than 33% of US stocks

Return on assets
−6.5%

Higher than 30% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,300 US stocks Ticker Nerd covers, among those reporting the figure.

Statistics

Key statistics

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • 908 Devices, Inc. has a market value of $360.5M and an enterprise value of $266.4M.

  • Revenue in the twelve months to 30 June 2026: $60.8M. The latest quarter grew 23.3% year on year.

  • Net income over the same four quarters: −$34.7M, a −57.0% net margin.

  • Diluted earnings per share, trailing twelve months: −$0.95.

  • Free cash flow in the twelve months to 30 June 2026: $615K.

  • Shares outstanding: 38.1M.

  • 908 Devices, Inc. employs 172 people — $354K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 21 Nov 2026

Data provided by Twelve Data

Peers

MASS and its peers

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Devices
CompanyMarket capTKN rank
MASS908 Devices, Inc.$360.5M77
CERSCerus Corp.$373.6M96
CVCapsoVision, Inc.$325.1M18
VMDViemed Healthcare, Inc.$323.9M99
MOBIMobia Medical, Inc.$392.1M2
SENSSenseonics Holdings, Inc.$418.7M33
SIShoulder Innovations, Inc.$419.5M63

Take a look at MASS’s peer groups, ranked by the model: healthcare stocks.

Look up any of the roughly 4,300 stocks we score.

The rank is the raw material. Whether the rules would actually own 908 Devices, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

FAQ

Questions about MASS

What is the MASS stock price forecast for 2026-2027?

The median 12-month analyst price target for 908 Devices, Inc. is $14. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is MASS stock a buy right now?

Of the 6 analysts covering 908 Devices, Inc., 6 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks 908 Devices, Inc. 77 out of 100 across roughly 4,300 US stocks as at 21 Nov 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank MASS?

As at 21 Nov 2026, 908 Devices, Inc. ranks 77 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,300 US stocks, built from its factor families. Its strongest factor family is Growth (87 of 100).

Will MASS stock go up?

No one can know that. What the data says: the median 12-month target from 6 analysts is $14, and Ticker Nerd's factor model ranks 908 Devices, Inc. 77 out of 100 as at 21 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the MASS stock forecast for 2030?

No analyst covering 908 Devices, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for MASS are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $14 to $14 over the next 12 months.

How has MASS stock performed over the past year?

908 Devices, Inc. returned +52.1% over the 12 months to 20 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.

What does 908 Devices, Inc. do?

908 Devices Inc. is a medical technology company that develops handheld and desktop chemical analysis instruments for point-of-need testing. Its product portfolio centers on portable mass spectrometry and spectroscopy systems used to detect, identify, and monitor unknown substances in demanding environments.

Company

About 908 Devices, Inc.

908 Devices Inc. is a medical technology company that develops handheld and desktop chemical analysis instruments for point-of-need testing. Its product portfolio centers on portable mass spectrometry and spectroscopy systems used to detect, identify, and monitor unknown substances in demanding environments. The company’s devices support applications across health, safety, and defense, including field screening for hazardous chemicals, drugs, explosives, gases, and other materials that require rapid analysis outside traditional laboratories. 908 Devices also serves markets such as life sciences research, bioprocessing, biopharma, forensics, and industrial analysis with tools designed for faster, more accessible sample interrogation. Headquartered in Burlington, Massachusetts, 908 Devices focuses on making advanced analytical capabilities available in compact formats that can be used directly at the point of need.

CEO Dr. Kevin J. Knopp Ph.D. · 172 employees · United States · https://908devices.com